PLoS ONE (Jan 2012)

Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.

  • Tjinta Brinkhuizen,
  • Karin van den Hurk,
  • Véronique J L Winnepenninckx,
  • Joep P de Hoon,
  • Ariënne M van Marion,
  • Jürgen Veeck,
  • Manon van Engeland,
  • Maurice A M van Steensel

DOI
https://doi.org/10.1371/journal.pone.0051710
Journal volume & issue
Vol. 7, no. 12
p. e51710

Abstract

Read online

BackgroundThe genetic background of Basal Cell Carcinoma (BCC) has been studied extensively, while its epigenetic makeup has received comparatively little attention. Epigenetic alterations such as promoter hypermethylation silence tumor suppressor genes (TSG) in several malignancies.ObjectiveWe sought to analyze the promoter methylation status of ten putative (tumor suppressor) genes that are associated with Sonic Hedgehog (SHH), WNT signaling and (hair follicle) tumors in a large series of 112 BCC and 124 healthy control samples by methylation-specific PCR.ResultsGene promoters of SHH (P = 0.016), adenomatous polyposis coli (APC) (P = 0.003), secreted frizzled-related protein 5 (SFRP5) (P = 0.004) and Ras association domain family 1A (RASSF1A) (P = 0.023) showed significantly more methylation in BCC versus normal skin. mRNA levels of these four genes were reduced for APC and SFRP5 in BCC (n = 6) vs normal skin (n = 6). Down regulation of SHH, APC and RASSF1A could be confirmed on protein level as well (PConclusionsWe provide evidence that promoter hypermethylation of key players within the SHH and WNT pathways is frequent in BCC, consistent with their known constitutive activation in BCC. Epigenetic gene silencing putatively contributes to BCC tumorigenesis, indicating new venues for treatment.